Skip to main content

Want a detailed portfolio tracker?

MiNK Therapeutics (INKT) P/E (2021 - 2026)

MiNK Therapeutics (INKT) P/E from Oct 15, 2021 to Jul 20, 2026. The TTM MiNK Therapeutics (INKT) P/E is -3.56. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MiNK Therapeutics (INKT)

YearP/EChange
2026-3.56-8.19%
2025-3.88+109.97%
2024-1.85+18.14%
2023-1.57-28.58%
2022-2.19-58.15%
2021-5.24N/A

Comparison MiNK Therapeutics (INKT) P/E with competitors

MiNK Therapeutics (INKT) P/E is -3.56.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.12%
ENLVEnlivex Ltd0.07-102.10%
FGENFibroGen Inc0.24-106.73%
CHRSCoherus Biosciences Inc0.85-123.80%
FBIOFortress Biotech Inc0.95-126.62%
ORMPOramed Pharmaceuticals Inc1.50-142.16%
AGENAgenus Inc3.01-184.43%
INVAInnoviva Inc3.15-188.48%
VXRTVaxart Inc3.55-199.58%
CRMDCorMedix Inc3.63-201.79%
CVACCureVac N.V.4.45-224.71%
GLPGGalapagos NV4.86-236.30%
SRPTSarepta Therapeutics Inc4.88-236.96%
ABEOAbeona Therapeutics Inc5.39-251.13%
ABUSArbutus Biopharma Corp5.60-256.97%
ZVRAZevra Therapeutics Inc5.89-265.15%
SPROSpero Therapeutics Inc6.23-274.72%
CGENCompugen Ltd6.31-277.12%
RIGLRigel Pharmaceuticals6.87-292.78%
SLXNSilexion Therapeutics Corp7.30-304.67%
OMEROmeros Corporation9.26-359.73%
AUPHAurinia Pharmaceuticals Inc9.58-368.88%
PLXProtalix BioTherapeutics Inc10.89-405.52%
ACADAcadia Pharmaceuticals Inc11.73-429.02%
TBPHTheravance Biopharma Inc12.26-443.99%
ADMAAdma Biologics Inc12.42-448.36%
HRMYHarmony Biosciences Holdings Inc13.82-487.70%
SABSSAB Biotherapeutics Inc14.14-496.56%
NAGENiagen Bioscience Inc14.82-515.69%
REGNRegeneron Pharmaceuticals Inc15.86-544.82%
PBYIPuma Biotechnology Inc17.32-585.75%
CPRXCatalyst Pharmaceuticals Inc17.44-589.22%
EXELExelixis Inc17.54-591.99%
TGTXTG Therapeutics Inc18.97-632.05%
MDXGMimedx Group Inc20.55-676.56%
XOMAXOMA Royalty Corp22.87-741.72%
ARGXArgen X SE24.30-781.65%
CTMXCytomX Therapeutics Inc24.82-796.32%
XOMAOXOMA Royalty Corp25.34-811.01%
HALOHalozyme Therapeutics Inc25.62-818.84%
XOMAPXOMA Royalty Corp25.67-820.14%
VRTXVertex Pharmaceuticals Inc27.99-885.35%
RPRXRoyalty Pharma plc - Class A28.69-904.79%
SLNOSoleno Therapeutics Inc29.02-913.98%
ASNDAscendis Pharma A/S30.09-944.01%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1163.57%
APLSApellis Pharmaceuticals Inc39.02-1194.68%
BMRNBiomarin Pharmaceutical Inc42.21-1284.19%
KRYSKrystal Biotech Inc45.34-1372.05%
ONCBeiGene Ltd69.54-2050.86%
PHARPharming Group N.V.75.03-2204.74%
TECHBio-Techne Corp101.96-2960.30%
VCELVericel Corp109.92-3183.69%
ALNYAlnylam Pharmaceuticals Inc117.96-3409.34%
GMABGenmab140.29-4035.66%
TLXTelix Pharmaceuticals Ltd162.15-4648.97%
CORTCorcept Therapeutics Inc212.86-6071.42%